Complement Therapeutics

Developer of a biotechnology platform designed to treat chronic diseases driven by the dysregulation of the complement system. The company's platform aims to design a methodology that stratifies patie...

Healthcare

London, United Kingdom

Founded 2020

34 employees

Website

Valuation

Share Price

N/A

Total Raised

$84.1M

Last Round

N/A

Investors

+12 other investors

View all 12 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock Complement Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required